With the first FDA-approved drug for weight management in people with rare genetic disorders of obesity – its first new drug approval – shares of this small biotech are surging. CLICK HERE.
By using this site, you agree to the storage of cookies on your device for enhanced navigation, site analysis, and GATS's marketing. Data sharing with social media platforms might occur based on the privacy choices you make on those platforms. For specifics, see our Privacy Policy.OkayPrivacy policy